Par Drugs & Chemicals Ltd. NSE: PAR

Par Drugs & Chemicals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Par Drugs & Chemicals Ltd.: Is Infosys Ltd. worth buying?
Item: Par Drugs & Chemicals Ltd.
Rating: 2.422416625
Author: Trendlyne DVM scores

Falling Comet

about

Par Drugs & Chemicals is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as “bulk drugs” or “bulk actives” are the principa...

96.41 1.89 (2.00%)

72.33% Fall from 52W High

2,326

NSE Volume

NSE 29 Aug, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

55.0 / 100

Affordable Valuation

54.3 / 100

Technically Bearish

29.5 / 100

Falling Comet These stocks are with medium quality with average financials but with good valuation score. However, their weak technical aspects reduces the investor interest. View Similar Embed DVM

No estimates available

Par Drugs & Chemicals Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Par Drugs & Chemicals Ltd. worth buying?

35 Votes:

Buy 80.0%

Sell 8.57%

Hold 11.43%

Par Drugs & Chemicals Ltd. Live Share Price Today, Share Analysis and Chart

Par Drugs & Chemicals is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as “bulk drugs” or “bulk actives” are the principa...

72.33% Fall from 52W High

SWOT Analysis

Par Drugs & Chemicals Live Price Chart